Benzinga
Benzinga
Benzinga
mercoledì, settembre 30

Oncolytics Biotech Inc

ONCYNASDAQ
Trade with Public
Trade with Public
$0.6745
0.01151.73%
In chiusura: Sep 28, 5:00 PM EST
$0.6870
0.0243.62%
Pre-mercato: 4:39 AM EST
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaRapporto azionario

Oncolytics Biotech Analyst Price Targets

Wall Street analyst price targets and consensus rating for Oncolytics Biotech (ONCY).

Price Target Range — 11 Quarters

Analyst Consensus — 6 Analysts

5Buy
1Hold
Consensus RatingBuy# Analysts6Avg. Consensus PT$5Upside to Avg. PT+579.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →
DateFirmAnalystActionRating ChangePrice Target
Aug 19, 2026HC Wainwright & Co.Patrick R. TrucchioPT CutBuy$10→$5
May 26, 2026HC Wainwright & Co.Patrick R. TrucchioMaintainedBuy$10
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Oncolytics Biotech, Lowers Price Target to $5

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Oncolytics Biotech (NASDAQ:ONCY) with a Buy and lowers the price target from $10 to $5.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Oncolytics Biotech, Maintains $10 Price Target

HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Oncolytics Biotech (NASDAQ:ONCY) with a Buy and maintains $10 price target.
Benzinga Newsdesk

PRO
Watching Oncolytics Biotech; Zacks Small-Cap Research Gives Stock $6 Price Valuation

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Oncolytics Biotech, Raises Price Target to $10

HC Wainwright & Co. analyst Patrick R. Trucchio maintains Oncolytics Biotech (NASDAQ:ONCY) with a Buy and raises the price target from $5 to $10.
Benzinga Newsdesk

PRO
Lake Street Initiates Coverage On Oncolytics Biotech with Buy Rating, Announces Price Target of $7

Lake Street analyst Chad Messer initiates coverage on Oncolytics Biotech (NASDAQ:ONCY) with a Buy rating and announces Price Target of $7.
Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Oncolytics Biotech, Maintains $5 Price Target

HC Wainwright & Co. analyst Patrick Trucchio reiterates Oncolytics Biotech (NASDAQ:ONCY) with a Buy and maintains $5 price target.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved